Anthranilamide inhibitors of factor Xa

被引：18

作者：

Mendel, David ^{[1
]}

Marquart, Angela L. ^{[1
]}

Joseph, Sajan ^{[1
]}

Waid, Philip ^{[1
]}

Yee, Ying K. ^{[1
]}

Tebbe, Anne Louise ^{[1
]}

Ratz, Andrew M. ^{[1
]}

Herron, David K. ^{[1
]}

Goodson, Theodore ^{[1
]}

Masters, John J. ^{[1
]}

Franciskovich, Jeffry B. ^{[1
]}

Tinsley, Jennifer M. ^{[1
]}

Wiley, Michael R. ^{[1
]}

Weir, Leonard C. ^{[1
]}

Kyle, Jeffrey A. ^{[1
]}

Klimkowski, Valentine J. ^{[1
]}

Smith, Gerald F. ^{[1
]}

Towner, Richard D. ^{[1
]}

Froelich, Larry L. ^{[1
]}

Buben, John ^{[1
]}

Craft, Trelia J. ^{[1
]}

机构：

[1] Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 17期

关键词：

protease inhibitor; factor Xa; anticoagulant;

D O I：

10.1016/j.bmcl.2007.06.051

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

SAR about the B-ring of a series of N-2-aroyl anthranilamide factor Xa (tXa) inhibitors is described. B-ring o-aminoalkylether and B-ring p-amine probes of the S1' and S4 sites, respectively, afforded picomolar fXa inhibitors that performed well in in vitro anticoagulation assays. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：4832 / 4836

页数：5

共 50 条

[11] Factor Xa inhibitors
Al-Obeidi, F
Ostrem, JA
EXPERT OPINION ON THERAPEUTIC PATENTS, 1999, 9 (07) : 931 - 953
[12] Factor Xa inhibitors
Kunitada, S
Nagahara, T
CURRENT PHARMACEUTICAL DESIGN, 1996, 2 (05) : 531 - 542
[13] Factor Xa inhibitors
Lloyd, AW
DRUG DISCOVERY TODAY, 1998, 3 (03) : 141 - 141
[14] Inhibitors of Factor Xa
不详
EXPERT OPINION ON THERAPEUTIC PATENTS, 2001, 11 (05) : 891 - 895
[15] Design, synthesis, and SAR of anthranilamide-based factor Xa inhibitors incorporating substituted biphenyl P4 motifs
Zhang, PL
Bao, L
Zuckett, JMF
Goldman, EA
Jia, ZZJ
Arfsten, A
Edwards, S
Sinha, U
Hutchaleelaha, A
Park, G
Lambing, JL
Hollenbach, SJ
Scarborough, RM
Zhu, BY
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) : 983 - 987
[16] An antidote to factor Xa inhibitors
Harrison Charlotte
Nature Reviews Drug Discovery, 2013, 12 (5) : 346 - 346
[17] Anticoagulation by factor Xa inhibitors
Orfeo, T.
Butenas, S.
Brummel-Ziedins, K. E.
Gissel, M.
Mann, K. G.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (08) : 1745 - 1753
[18] Antidote to factor Xa inhibitors
Gregory B. Lim
Nature Reviews Cardiology, 2016, 13 (1) : 4 - 4
[19] Structure-activity relationships of anthranilamide-based factor Xa inhibitors containing piperidinone and pyridinone P4 moieties
Corte, James R.
Fang, Tianan
Pinto, Donald J. P.
Han, Wei
Hu, Zilun
Jiang, Xiang-Jun
Li, Yun-Long
Gauuan, Jolicia F.
Hadden, Mark
Orton, Darren
Rendina, Alan R.
Luettgen, Joseph M.
Wong, Pancras C.
He, Kan
Morin, Paul E.
Chang, Chong-Hwan
Cheney, Daniel L.
Knabb, Robert M.
Wexler, Ruth R.
Lam, Patrick Y. S.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (09) : 2845 - 2849
[20] Anthranilamide-based N,N-dialkylbenzamidines as potent and orally bioavailable factor Xa inhibitors: P4 SAR
Zhang, Penglie
Bao, Liang
Fan, Jingmei
Jia, Zhaozhong J.
Sinha, Uma
Wong, Paul W.
Park, Gary
Hutchaleelaha, Athiwat
Scarborough, Robert M.
Zhu, Bing-Yan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2186 - 2189

← 1 2 3 4 5 →